Steroids as an adjunct for reducing the incidence of proliferative vitreoretinopathy after rhegmatogenous retinal detachment surgery: a systematic review and meta-analysis

References

• CharterisDGSethiCSLewisGPFisherSKProliferative vitreoretinopathy – developments in adjunctive treatment and retinal pathologyEye (Lond)200216436937412101443
   PubMed Web of Science ®Google Scholar
• HeimannHBartz-SchmidtKUBornfeldNScleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment: a prospective randomized multicenter clinical studyOphthalmology2007114122142215418054633
   PubMed Web of Science ®Google Scholar
• WickhamLBunceCWongDMcGurnDCharterisDGRandomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomyOphthalmology2007114469870417398320
   PubMed Web of Science ®Google Scholar
• CharterisDGAylwardGWWongDA randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathyOphthalmology2004111122240224515582080
   PubMed Web of Science ®Google Scholar
• FekratSde JuanEJCampochiaroPAThe effect of oral 13-cis-retinoic acid on retinal redetachment after surgical repair in eyes with proliferative vitreoretinopathyOphthalmology199510234124187891978
   PubMed Web of Science ®Google Scholar
• ChangYCHuDNWuWCEffect of oral 13-cis-retinoic acid treatment on postoperative clinical outcome of eyes with proliferative vitreoretinopathyAm J Ophthalmol2008146344044618599016
   PubMed Web of Science ®Google Scholar
• GongLJiangDZhuXGuoLCurcumin inhibits the proliferation of cultured human fetal retinal pigment epithelium cellsYan Ke Xue Bao2004204246248 Chinese15656371
   PubMedGoogle Scholar
• AnJBMaJXLiuDYThe effect of curcumin on DNA content, mitochondrial transmembrane potential and calcium of rabbit cultured retinal pigment epithelial cellsZhonghua Yan Ke Za Zhi2009453210215 Chinese19575913
   PubMedGoogle Scholar
• AlexAFSpitznasMTittelAPKurtsCEterNInhibitory effect of epigallocatechin gallate (EGCG), resveratrol, and curcumin on proliferation of human retinal pigment epithelial cells in vitroCurr Eye Res201035111021103320958191
   PubMed Web of Science ®Google Scholar
• ShinoharaKTanakaMSakumaTKobayashiYEfficacy of daunorubicin encapsulated in liposome for the treatment of proliferative vitreoretinopathyOphthalmic Surg Lasers Imaging200334429930512875458
   PubMedGoogle Scholar
• CaiJWeiRMaXZhuHLiYCytotoxic effects of antiproliferative agents on human retinal glial cells in vitroInt Ophthalmol200124422523112678400
   PubMedGoogle Scholar
• WuWCKaoYHTsengHYThe cell cycle distribution of cultured human retinal pigmented epithelial cells under exposure of anti-proliferative drugsJ Ocul Pharmacol Ther2003191839012648307
   PubMed Web of Science ®Google Scholar
• ChenWChenHHouPMidterm results of low-dose intravitreal triamcinolone as adjunctive treatment for proliferative vitreoretinopathyRetina20113161137114221317835
   PubMed Web of Science ®Google Scholar
• CheemaRAPeymanGAFangTTriamcinolone acetonide as an adjuvant in the surgical treatment of retinal detachment with proliferative vitreoretinopathyOphthalmic Surg Lasers Imaging200738536537017955840
   PubMedGoogle Scholar
• JonasJBHaylerJKPanda-JonasSIntravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathyBr J Ophthalmol20008491064106710966969
   PubMed Web of Science ®Google Scholar
• AcarNKapranZAltanTUnverYBPasaogluEPars plana vitrectomy with and without triamcinolone acetonide assistance in pseudophakic retinal detachment complicated with proliferative vitreoretinopathyJpn J Ophthalmol201054433133720700802
   PubMed Web of Science ®Google Scholar
• HowardJEHarveyAMCareyRAWinkenwerderWLEffects of pituitary adrenocorticotropic hormone (ACTH) on the hypersensitive stateJ Am Med Assoc1950144161347134914778745
   PubMed Web of Science ®Google Scholar
• ShenLYouYSunSIntraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40-mg posterior subtenon applicationOphthalmology2010117122365237120678801
   PubMed Web of Science ®Google Scholar
• MankowskaARejdakROleszczukADecrease of the postoperative inflammatory reaction during pars plana vitrectomy (PPV) after administration of triamcinolone acetonideKlin Oczna20081104–6151154 Polish18655452
   PubMedGoogle Scholar
• WellerMWiedemannPHeimannKProliferative vitreoretinopathy – is it anything more than wound healing at the wrong place?Int Ophthalmol19901421051172187005
   PubMed Web of Science ®Google Scholar
• PeymanGASchulmanJAIntravitreal Surgery: Principles and PracticeNorwalk, CT, USAAppleton & Lange1994
   Google Scholar
• FurinoCMicelliFTBosciaFTriamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathyRetina200323677177614707825
   PubMed Web of Science ®Google Scholar
• SakamotoTIshibashiTVisualizing vitreous in vitrectomy by triamcinoloneGraefes Arch Clin Exp Ophthalmol200924791153116319543906
   PubMed Web of Science ®Google Scholar
• SonodaKHEnaidaHUenoAPars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series studyBr J Ophthalmol20038781010101412881346
   PubMed Web of Science ®Google Scholar
• MoherDCookDJJadadARAssessing the quality of reports of randomised trials: Implications for the conduct of meta-analysesHealth Technol Assess1999312198
   Google Scholar
• BeggCBMazumdarMOperating characteristics of a rank correlation test for publication biasBiometrics1994504108811017786990
   PubMed Web of Science ®Google Scholar
• EggerMDaveySGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
   PubMed Web of Science ®Google Scholar
• KoernerFKoerner-StiefboldUGarwegJGSystemic corticosteroids reduce the risk of cellophane membranes after retinal detachment surgery: a prospective randomized placebo-controlled double-blind clinical trialGraefes Arch Clin Exp Ophthalmol2012250798198722270216
   PubMed Web of Science ®Google Scholar
• DehghanMHAhmadiehHSoheilianMEffect of oral prednisolone on visual outcomes and complications after scleral bucklingEur J Ophthalmol201020241942319924670
   PubMed Web of Science ®Google Scholar
• AhmadiehHFeghhiMTabatabaeiHTriamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trialOphthalmology2008115111938194318584876
   PubMed Web of Science ®Google Scholar
• PatelNNBunceCAsariaRHCharterisDGResources involved in managing retinal detachment complicated by proliferative vitreoretinopathyRetina200424688388715579985
   PubMed Web of Science ®Google Scholar
• GilbertCHiscottPUngerWGriersonIMcLeodDInflammation and the formation of epiretinal membranesEye (Lond)19882SupplS140S1563076143
   PubMedGoogle Scholar
• JoshiMAgrawalSChristoforidisJBInflammatory mechanisms of idiopathic epiretinal membrane formationMediators Inflamm20132013192582
   Web of Science ®Google Scholar
• RasierRGormusUArtunayOVitreous levels of VEGF, IL-8, and TNF-alpha in retinal detachmentCurr Eye Res201035650550920465445
   PubMed Web of Science ®Google Scholar
• RickerLJKijlstraAKesselsAGInterleukin and growth factor levels in subretinal fluid in rhegmatogenous retinal detachment: a case-control studyPLoS One201164e1914121556354
   PubMed Web of Science ®Google Scholar
• GilliesMCSimpsonJMLuoWA randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year resultsArch Ophthalmol2003121566767312742844
   PubMedGoogle Scholar
• JonasJBAkkoyunIBuddeWMKreissigIDegenringRFIntravitreal reinjection of triamcinolone for exudative age-related macular degenerationArch Ophthalmol2004122221822214769599
   PubMedGoogle Scholar
• BlumenkranzMSClaflinAHajekASSelection of therapeutic agents for intraocular proliferative disease. Cell culture evaluationArch Ophthalmol198410245986046704019
   PubMedGoogle Scholar
• WilliamsRGChangSComarattaMRSimoniGDoes the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy?Graefes Arch Clin Exp Ophthalmol199623484965038858355
   PubMed Web of Science ®Google Scholar